scispace - formally typeset
G

Gemma Migneco

Researcher at University of Leeds

Publications -  11
Citations -  391

Gemma Migneco is an academic researcher from University of Leeds. The author has contributed to research in topics: Oncolytic virus & Immune system. The author has an hindex of 4, co-authored 11 publications receiving 255 citations. Previous affiliations of Gemma Migneco include St James's University Hospital.

Papers
More filters
Journal ArticleDOI

Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition.

TL;DR: It is found that HSVGM-CSF supported activation of anti-melanoma immunity via monocyte-mediated type I interferon production, which activates NK cells, and viral maturation of immature dendritic cells (iDCs) into potent antigen-presenting cells for cytotoxic T lymphocyte (CTL) priming.
Journal ArticleDOI

Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia

TL;DR: It is demonstrated that reovirus is directly cytotoxic against CLL, which requires replication-competent virus, and phenotypically and functionally activates patient NK cells via a monocyte-derived interferon-α (IFNα)-dependent mechanism, and enhances ADCC-mediated killing of CLL in combination with anti-CD20 antibodies.
Journal ArticleDOI

Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma

TL;DR: In this paper, plasmacytoid dendritic cells (pDC) have been implicated in the pathogenesis of autoimmune diseases, such as scleroderma (SSc), which has been derived from indirect evidence using ex vivo human samples or mouse pDC in vivo.